drugset

drugset / Trial / NCT00219609

Assessment Of Safety Of UK-390,957

NCT00219609 ↗

Phase 2/3 Completed 1058 enrolled Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To determine whether UK-390,957 is a safe treatment for premature ejaculation.

Timeline

Start: 2005-01
Primary completion: 2006-03
Completion: 2006-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	UK-390,957	Small molecule	—	—

Indications